Tolerance in liver transplantation

被引:33
作者
Bishop, G. Alex [1 ,2 ,3 ]
Bertolino, Patrick D. [2 ,3 ]
Bowen, David G. [2 ,3 ]
McCaughan, Geoffrey W. [2 ,3 ]
机构
[1] Royal Prince Alfred Hosp, Collaborat Transplantat Lab, Sydney, NSW 2006, Australia
[2] Univ Sydney, Sydney, NSW 2006, Australia
[3] Royal Prince Alfred Hosp, AW Morrow Gastroenterol & Liver Lab, Centenary Inst, Sydney, NSW 2006, Australia
基金
英国医学研究理事会;
关键词
Liver transplantation; Immune tolerance; Operational tolerance; Clinical transplantation; T-CELL-ACTIVATION; IMMUNOSUPPRESSION INHIBITS REJECTION; HEART-KIDNEY TRANSPLANTATION; RANDOMIZED CONTROLLED-TRIAL; LONG-TERM OUTCOMES; OPERATIONAL TOLERANCE; GRAFT ACCEPTANCE; PASSENGER LEUKOCYTES; PERIPHERAL-BLOOD; CLINICAL TRANSPLANTATION;
D O I
10.1016/j.bpg.2012.01.003
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Operational tolerance (OT) in liver transplant patients occurs much more frequently than OT of other transplanted organs; however the rate of OT varies considerably with the centre and patient population. Rates of OT range from 15% of the total liver transplant (LTX) patient population down to less than 5%. This review examines the reports of liver OT and compares the factors that could contribute, to this variation. Multiple factors were examined, including the time from transplantation when weaning of immunosuppression (IS) was commenced, the rapidity of weaning, the contribution of maintenance and induction IS and the patient population transplanted. The approaches that might be used to increase the likelihood of OT are discussed and the approaches to monitoring OT in LTX patients are reviewed. (c) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:73 / 84
页数:12
相关论文
共 86 条
[1]   Heterologous immunity provides a potent barrier to transplantation tolerance [J].
Adams, AB ;
Williams, MA ;
Jones, TR ;
Shirasugi, N ;
Durham, MM ;
Kaech, SM ;
Wherry, EJ ;
Onami, T ;
Lanier, JG ;
Kokko, KE ;
Pearson, TC ;
Ahmed, R ;
Larsen, CP .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (12) :1887-1895
[2]   Brief report: Chimerism and tolerance in a recipient of a deceased-donor liver transplant [J].
Alexander, Stephen I. ;
Smith, Neil ;
Hu, Min ;
Verran, Deborah ;
Shun, Albert ;
Dorney, Stuart ;
Smith, Arabella ;
Webster, Boyd ;
Shaw, Peter John ;
Lammi, Ahti ;
Stormon, Michael O. .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (04) :369-374
[3]   Randomized controlled trial of total immunosuppression withdrawal in liver transplant recipients: Role of ursodeoxycholic acid [J].
Assy, Nimer ;
Adams, Paul C. ;
Myers, Paul ;
Simon, Verra ;
Minuk, Gerry Y. ;
Wall, William ;
Ghent, Cameron N. .
TRANSPLANTATION, 2007, 83 (12) :1571-1576
[4]   ATG-Fresenius Treatment and Low-Dose Tacrolimus: Results of a Randomized Controlled Trial in Liver Transplantation [J].
Benitez, C. E. ;
Puig-Pey, I. ;
Lopez, M. ;
Martinez-Llordella, M. ;
Lozano, J. J. ;
Bohne, F. ;
Londono, M. C. ;
Garcia-Valdecasas, J. C. ;
Bruguera, M. ;
Navasa, M. ;
Rimola, A. ;
Sanchez-Fueyo, A. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 (10) :2296-2304
[5]  
Benseler V, P NATL ACAD IN PRESS
[6]   The liver: A special case in transplantation tolerance [J].
Benseler, Volker ;
McCaughan, Geoffrey W. ;
Schlitt, Hans J. ;
Bishop, G. Alex ;
Bowen, David G. ;
Bertolino, Patrick .
SEMINARS IN LIVER DISEASE, 2007, 27 (02) :194-213
[7]   Antigen-specific primary activation of CD8+ T cells within the liver [J].
Bertolino, P ;
Bowen, DG ;
McCaughan, GW ;
Fazekas de St Groth, B .
JOURNAL OF IMMUNOLOGY, 2001, 166 (09) :5430-5438
[8]   Approaching the Promise of Operational Tolerance in Clinical Transplantation [J].
Bishop, G. Alex ;
Ierino, Francesco L. ;
Sharland, Alexandra F. ;
Hall, Bruce M. ;
Alexander, Stephen I. ;
Sandrin, Mauro S. ;
Coates, P. Toby ;
McCaughan, Geoffrey W. .
TRANSPLANTATION, 2011, 91 (10) :1065-1074
[9]  
Bishop G Alex, 2008, Hepatology, V48, P2082, DOI 10.1002/hep.22692
[10]  
Bishop GA, 1996, J IMMUNOL, V156, P4925